The global precision medicine market is expected to grow at an estimated CAGR of 10.5% from 2018 to 2029. In the precision medicine market, the Diagnostic Tool companies’ segment is dominating the global market and accounted for $23.36 billion in 2018 due to the development of large number of diagnostic and genetic tests.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 212-page report you will receive 98 tables and 63 figures– all unavailable elsewhere.

The 212-page report provides clear detailed insight into the global precision medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Download Free Sample Pages of this report

Report Scope

Global Precision Medicine Market forecasts from 2019-2029

Along with revenue prediction for the overall market for the global precision medicine market, our investigation shows forecasts to 2029 for the market segmented by technology:

  • Companion Diagnostics
  • Biomarker-based Test
  • Targeted Therapeutics
  • Pharmacogenomics
  • Molecular Diagnostics

The report discusses key trends, developments and participants.

This report breaks down the precision medicine market forecast to 2029 by end-users:

  • Pharmaceuticals & Biotechnology Companies
  • Diagnostic Companies
  • Healthcare IT/Big Data Companies
  • Clinical Laboratories

The report discusses key trends, developments and participants.

This report also breaks down the precision medicine market forecast to 2029 by therapeutic application:

  • Cancer
  • Cardiovascular Diseases
  • Central Nervous System
  • Infectious Diseases
  • Immunology
  • Others

The report discusses key trends, developments and participants.

This study provides precision medicine market forecasts to 2029 for these regional markets:

  • North America: US & Canada
  • Europe: Germany, UK, France, Italy, Spain, Rest of Europe
  • Asia-Pacific: China, japan, India, Australia, South Korea, Rest of Asia-Pacific
  • Middle East & Africa: South Africa, Saudi Arabia, Rest of Middle East & Africa
  • Latin America: Brazil, Mexico, Rest of Latin America

For each regional market, the report discusses key trends, developments and participants.

This report profiles selected leading companies that are the main players in the global precision medicine market:

  • Abbott
  • Danaher Corporation
  • GE Healthcare
  • GlaxoSmithKline
  • Illumina, Inc.
  • Johnson & Johnson
  • Laboratory Corporation of America Holdings
  • Novartis
  • Pfizer
  • QIAGEN
  • Thermo Fisher Scientific, Inc.

Our study discusses the drivers, restraints as well as the opportunities in the global precision medicine market.

This study also analyzed the global precision medicine market with Porter’s Five Forces Analysis as well as Value Chain Analysis

This report discusses selected market developments in the precision medicine market: partnership, collaboration, join venture, acquisitions, product launch, product development, expansions, patents, approvals.